Eastham Karin's Form 4 filing
Veracyte, Inc. (VCYT) · filed Jan 6, 2025
- Accession no.
- 0001384101-25-000002
- Filed
- Jan 6, 2025
- Trade date
- Jan 2, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $403.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eastham KarinCIK 0001231845 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $5.28 | +$52,800 | 28,497 | Direct | |
| Jan 2, 2025 | Common Stock | SSaleDisposed | −5,309 | $40.12F2 | −$212,997.08 | 23,188 | Direct | |
| Jan 2, 2025 | Common Stock | SSaleDisposed | −4,691 | $40.50F3 | −$189,985.5 | 18,497 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents weighted average sales price. Sale prices for the transactions range from $39.46 to $40.36. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents weighted average sales price. Sale prices for the transactions range from $40.37 to $40.78. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.